MTN-030/IPM 041 News Releases

Second early phase study of 90-day vaginal ring containing dapivirine and contraceptive shows promise as dual-purpose product for preventing both HIV and pregnancy
26-January-2021

First clinical trial of new dapivirine ring with both anti-HIV drug and contraceptive finds ring is well-tolerated with no safety concerns
24-October-2018

MTN begins first trial of new dapivirine ring with both anti-HIV drug and contraceptive
03-May-2017